探索细胞癌中前转移性利基的分子和细胞机制
Xiao Zhou1, Ruirui Li2, Maode Lai3
1Department of Pathology, and Department of Pathology Sir Run Run Shaw Hospital, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Science (2019RU042), Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Molecular cancer
|April 23, 2025
概括
细胞癌 (RCC) 转移通过改变瘤微环境,创造了一个前转移性利基 (PMN). 针对PMN提供了一个有前途的策略来预防和治疗RCC传播.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 瘤微环境 瘤微环境
背景情况:
- 细胞癌 (RCC) 是一种普遍存在的癌症,死亡率高,主要是由于转移.
- 瘤转移包括形成一个转移前位 (PMN),促进二次瘤生长.
- RCC积极重塑遥远的微环境以建立PMN.
研究的目的:
- 审查RCC中前转移性利基形成的机制.
- 突出针对RCC中PMN的治疗潜力.
- 总结目前在RCC中检测和治疗PMN的策略.
主要方法:
- 对RCC转移和PMN形成研究的文献综述.
- 对参与PMN诱导的生物分子和信号通路的分析.
- 对针对PMN的治疗策略的评估.
主要成果:
- 来自RCC的生物分子诱导血管生成,改变血管透性,并创造一个免疫抑制的微环境.
- 细胞外矩阵重塑和代谢重编程是PMN形成的关键过程.
- 信号通路决定了RCC转移中的机体化.
结论:
- 了解PMN形成对于开发有效的RCC转移治疗至关重要.
- 准PMN为预防和治疗RCC传播提供了重要的治疗机会.
- 需要进一步的研究来开发和完善针对RCC的PMN向策略.
相关概念视频
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K


